📌 Conference Overview
Internal Forum on Medicinal Chemistry and Drug Delivery (IFMCDD 2026)
July 14–16, 2026 | Dubai, United Arab Emirates
The Internal Forum on Medicinal Chemistry and Drug Delivery (IFMCDD 2026) is a premier platform designed to bring together leading researchers, pharmaceutical scientists, medicinal chemists, formulation experts, industry innovators, and healthcare professionals from around the world. This forum aims to foster high-level scientific discussions, share cutting-edge research, and explore transformative advancements shaping the future of drug discovery and therapeutic technologies.
Held in the vibrant and globally connected city of Dubai, the conference will feature keynote sessions, plenary talks, technical presentations, panel discussions, and interactive workshops covering breakthroughs across medicinal chemistry and advanced drug delivery systems.
IFMCDD 2026 will provide an ideal environment to network, collaborate, and build partnerships between academia, industry, and clinical research institutions. Participants will gain insights into emerging trends, challenges, regulatory perspectives, and technological innovations influencing modern pharmaceutical development.
Why to Attend
- Gain insights from global experts on the latest advancements in nursing practices, healthcare technologies, and patient care strategies.
- Discover in digital health, AI in healthcare, telemedicine, and evidence-based nursing that are transforming clinical practice worldwide.
- Expert keynote panel discussions, and interactive sessions led by renowned nursing leaders and healthcare specialists.
- Participate designed to enhance your professional skills, leadership abilities, and research capabilities.
- Enjoy Singapore’s unique blend of modern attractions, cultural diversity, and world-class hospitality while attending the forum.
How can Attend
Researchers and Academics
Engineers and Technicians
Industry Leaders and Executives
Innovators and Entrepreneurs
Students
Healthcare Professionals interested in medical applications of 3D printing
Manufacturers
Investors
Policy Makers
